The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-Hydroxy-3-methoxy-5-trifluoromethylbenzoyl)-1,1-dioxo-1,2-dihydro-3H-1,3-benzothiazole ID: ALA4762003
PubChem CID: 68108876
Max Phase: Preclinical
Molecular Formula: C16H12F3NO5S
Molecular Weight: 387.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C(=O)N2CS(=O)(=O)c3ccccc32)cc(C(F)(F)F)c1O
Standard InChI: InChI=1S/C16H12F3NO5S/c1-25-12-7-9(6-10(14(12)21)16(17,18)19)15(22)20-8-26(23,24)13-5-3-2-4-11(13)20/h2-7,21H,8H2,1H3
Standard InChI Key: KHNOOWVYFIYSGN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
5.5140 -18.3744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5181 -19.1916 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2237 -18.7794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3251 -19.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3240 -20.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0320 -20.6842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0302 -19.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7389 -19.4521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7437 -20.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5281 -20.5251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0081 -19.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7851 -21.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2419 -21.9113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5854 -21.4661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8377 -22.2441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6372 -22.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1814 -21.7987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9205 -21.0198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1216 -20.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9819 -21.9629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4616 -20.4074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2625 -20.5699 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.2018 -19.6326 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.0386 -19.8231 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.8939 -23.1854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6941 -23.3510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
2 8 1 0
10 12 1 0
12 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
18 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
16 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.33Molecular Weight (Monoisotopic): 387.0388AlogP: 2.81#Rotatable Bonds: 2Polar Surface Area: 83.91Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.98CX Basic pKa: ┄CX LogP: 2.12CX LogD: 2.02Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.86Np Likeness Score: -0.83
References 1. Uda J,Kobashi S,Miyata S,Ashizawa N,Matsumoto K,Iwanaga T. (2020) Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity., 11 (10): [PMID:33062187 ] [10.1021/acsmedchemlett.0c00176 ]